Review
Version 2
Preserved in Portico This version is not peer-reviewed
Strategies for the Management of Spike Protein-Related Pathology
Version 1
: Received: 16 March 2023 / Approved: 20 March 2023 / Online: 20 March 2023 (04:37:02 CET)
Version 2 : Received: 9 April 2023 / Approved: 12 April 2023 / Online: 12 April 2023 (10:04:23 CEST)
Version 2 : Received: 9 April 2023 / Approved: 12 April 2023 / Online: 12 April 2023 (10:04:23 CEST)
A peer-reviewed article of this Preprint also exists.
Halma, M.T.J.; Plothe, C.; Marik, P.; Lawrie, T.A. Strategies for the Management of Spike Protein-Related Pathology. Microorganisms 2023, 11, 1308. Halma, M.T.J.; Plothe, C.; Marik, P.; Lawrie, T.A. Strategies for the Management of Spike Protein-Related Pathology. Microorganisms 2023, 11, 1308.
Abstract
In the wake of the Covid-19 crisis, a need has arisen to prevent and treat two related conditions, Covid vaccine injury and long Covid, both of which have a significant vascular component. Therefore, the management of these conditions require the development of strategies to prevent or dissolve blood clots and restore circulatory health. This review summarizes the evidence on strategies that can be applied to treat both long and vaccine injuries based on similar mechanisms of action.
Keywords
Long Covid; Covid-19 vaccine; thrombosis; clots; inflammation; therapeutics
Subject
Medicine and Pharmacology, Medicine and Pharmacology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (1)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
Commenter: Matthew Halma
Commenter's Conflict of Interests: Author